| Pharmacotherapy: a pathophysiologic approach JT DiPiro, RL Talbert, GC Yee, GR Matzke, BG Wells, LM Posey McGraw-Hill Education 4, 141-2, 2014 | 3526 | 2014 |
| Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) GR Matzke, GR Aronoff, AJ Atkinson Jr, WM Bennett, BS Decker, ... Kidney international 80 (11), 1122-1137, 2011 | 496 | 2011 |
| Clinical pharmacokinetics of vancomycin GR Matzke, GG Zhanel, DRP Guay Clinical pharmacokinetics 11, 257-282, 1986 | 458 | 1986 |
| Pharmacokinetics of vancomycin in patients with various degrees of renal function GR Matzke, RW Mcgory, CE Halstenson, WF Keane Antimicrobial agents and chemotherapy 25 (4), 433-437, 1984 | 452 | 1984 |
| Validation of the five‐drug “Pittsburgh cocktail” approach for assessment of selective regulation of drug‐metabolizing enzymes RF Frye, GR Matzke, A Adedoyin, JA Porter, RA Branch Clinical Pharmacology & Therapeutics 62 (4), 365-376, 1997 | 311 | 1997 |
| Liver disease selectively modulates cytochrome P450–mediated metabolism RF Frye, NK Zgheib, GR Matzke, D Chaves‐Gnecco, M Rabinovitz, ... Clinical Pharmacology & Therapeutics 80 (3), 235-245, 2006 | 263 | 2006 |
| Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc Committe of the National Kidney Foundation WL Henrich, LE Agodoa, B Barrett, WM Bennett, RC Blantz, ... American journal of kidney diseases 27 (1), 162-165, 1996 | 236 | 1996 |
| Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis BH Heintz, GR Matzke, WE Dager Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (5 …, 2009 | 224 | 2009 |
| Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis PK Peterson, G Matzke, WF Keane Reviews of infectious diseases 9 (3), 604-612, 1987 | 185 | 1987 |
| Pharmacokinetics of cefepime in subjects with renal insufficiency RH Barbhaiya, CA Knupp, ST Forgue, GR Matzke, DRP Guay, KA Pittman Clinical Pharmacology & Therapeutics 48 (3), 268-276, 1990 | 157 | 1990 |
| Validity of creatinine clearance estimates in the assessment of renal function DR Luke, CE Halstenson, JA Opsahl, GR Matzke Clinical Pharmacology & Therapeutics 48 (5), 503-508, 1990 | 146 | 1990 |
| Hepatic drug metabolism and transport in patients with kidney disease TD Nolin, RF Frye, GR Matzke American journal of kidney diseases 42 (5), 906-925, 2003 | 143 | 2003 |
| Interactive preventive health record to enhance delivery of recommended care: a randomized trial AH Krist, SH Woolf, SF Rothemich, RE Johnson, JE Peele, ... The Annals of Family Medicine 10 (4), 312-319, 2012 | 138 | 2012 |
| Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis MS Joy, GR Matzke, RF Frye, PM Palevsky American journal of kidney diseases 31 (6), 1019-1027, 1998 | 131 | 1998 |
| Apparent biliary pseudolithiasis during ceftriaxone therapy KL Heim-Duthoy, EM Caperton, R Pollock, GR Matzke, D Enthoven, ... Antimicrobial agents and chemotherapy 34 (6), 1146-1149, 1990 | 126 | 1990 |
| Drug administration in patients with renal insufficiency: minimising renal and extrarenal toxicity GR Matzke, RF Frye Drug safety 16, 205-231, 1997 | 125 | 1997 |
| Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin S Flor, DR Guay, JA Opsahl, K Tack, GR Matzke Antimicrobial agents and chemotherapy 34 (12), 2436-2438, 1990 | 123 | 1990 |
| A primer on continuous renal replacement therapy for critically ill patients MS Joy, GR Matzke, DK Armstrong, MA Marx, BJ Zarowitz Annals of Pharmacotherapy 32 (3), 362-375, 1998 | 118 | 1998 |
| Pharmacotheray A Pathophysiologic Approach DJT Yee, MGR GC, BG Wells, LM Posey The McGraw Hill Companies, United States ofAmerica, 2008 | 106* | 2008 |
| Unintended immunomodulation: part II. Effects of pharmacological agents on cytokine activity KM ALKharfy, JA Kellum, GR Matzke Shock 13 (5), 346-360, 2000 | 104 | 2000 |
